The Cigna Group (CI) Price Target Boosted by $7 Following Better-than-Expected Q1

With an upside potential of 20.18% as of May 3, The Cigna Group (NYSE:CI) is included among the 10 Best Fortune 500 Stocks to Buy According to Analysts.

The Cigna Group (CI) Price Target Boosted by $7 Following Better-than-Expected Q1

The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

On May 1, Barclays increased its price target on The Cigna Group (NYSE:CI) from $303 to $310, while maintaining an ‘Overweight’ rating on the shares. The raised target, which represents an upside of almost 10% from the current levels, comes following the company’s Q1 report.

The Cigna Group (NYSE:CI) posted strong results for its first quarter on April 30, exceeding estimates in both profits and revenue. The company grew its adjusted EPS by around 16% YoY to $7.79, while its revenue of $68.5 billion was also up by 4.7% compared to last year. Notably, Cigna also revealed that it would exit subsidized plans offered under the Affordable ​Care Act, also known as Obamacare, at the end of this year.

The Cigna Group (NYSE:CI) also raised its full-year 2026 consolidated adjusted earnings per share outlook to at least $30.35, up from the prior guidance of $30.25 and slightly better than the consensus of $30.33.

While we acknowledge the risk and potential of CI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Blue Chip Stocks to Invest In According to Billionaires and 10 Best Fortune 500 Dividend Stocks to Invest In Right Now

Disclosure: None. Follow Insider Monkey on Google News.